Use of ACE inhibitors in Fontan: Rational or irrational?

International Journal of Cardiology

Volumn 210, Issue , 2016, Pages 95-99

  Wilson, Thomas G ^a,b,c   Iyengar, Ajay J ^a,b,c   Winlaw, David S ^d,e   Weintraub, Robert G ^a,b   Wheaton, Gavin R ^g   Gentles, Thomas L ^h   Ayer, Julian ^d,e   Grigg, Leeanne E ^f   Justo, Robert N ⁱ   Radford, Dorothy J ^j,k   Bullock, Andrew ^l   Celermajer, David S ^e,m   Dalziel, Kim ⁿ   Schilling, Chris ⁿ   D'Udekem, Yves ^a,b,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f ROYAL MELBOURNE HOSPITAL   (Australia)

^g WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^h STARSHIP CHILDREN S HOSPITAL   (New Zealand)

ⁱ LADY CILENTO CHILDREN S HOSPITAL   (Australia)

^j THE PRINCE CHARLES HOSPITAL   (Australia)

^k UNIVERSITY OF QUEENSLAND   (Australia)

^l PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^m ROYAL PRINCE ALFRED HOSPITAL   (Australia)

ⁿ UNIVERSITY OF MELBOURNE   (Australia)

more..

Author keywords

Angiotensin converting enzyme inhibitors; Fontan procedure; Heart defects congenital; Heart single ventricle; Heart ventricles abnormalities

Indexed keywords

CANDESARTAN; CAPTOPRIL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; IRBESARTAN; LISINOPRIL; PERINDOPRIL; QUINAPRIL; RAMIPRIL; TRANDOLAPRIL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIASTOLIC DYSFUNCTION; DRUG COST; DRUG INDICATION; FEMALE; FOLLOW UP; FONTAN PROCEDURE; HUMAN; HYPERTENSION; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIGRAINE; MITRAL VALVE REGURGITATION; PLEURA EFFUSION; PRIORITY JOURNAL; PROTEIN LOSING GASTROENTEROPATHY; SYSTOLIC DYSFUNCTION; TRICUSPID VALVE REGURGITATION; AUSTRALIA; HEART DEFECTS, CONGENITAL; NEW ZEALAND; REGISTER; YOUNG ADULT;

ADOLESCENT; ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; AUSTRALIA; CHILD; FEMALE; FOLLOW-UP STUDIES; FONTAN PROCEDURE; HEART DEFECTS, CONGENITAL; HUMANS; MALE; NEW ZEALAND; REGISTRIES; YOUNG ADULT;

EID: 84964637852     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.02.089     Document Type: Article

References (27)

1. Y. d'Udekem, A.J. Iyengar, J.C. Galati, V. Forsdick, R.G. Weintraub, G.R. Wheaton, and et al. Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand Circulation 130 2014 S32 S38
2. A.J. Iyengar, D.S. Winlaw, J.C. Galati, T.L. Gentles, R.G. Weintraub, R.N. Justo, and et al. The Australia and New Zealand Fontan registry: description and initial results from the first population-based Fontan registry Intern. Med. J. 44 2014 148 155
3. The Australia and New Zealand Fontan Registry Annual Report http://www.fontanregistry.com/research/current-research-projects.aspx 2013
4. T.G. Wilson, A. Iyengar, and Y. d'Udekem The use and misuse of ACE inhibitors in patients with single ventricle physiology Heart, Lung and Circulation Oct 27 2015 (pii: S1443-9506(15)01434-1)
5. D.T. Hsu, V. Zak, L. Mahony, L.A. Sleeper, A.M. Atz, J.C. Levine, and et al. Enalapril in infants with single ventricle: results of a multicenter randomized trial Circulation 122 2010 333 340
6. A.A. Kouatli, J.A. Garcia, T.M. Zellers, E.M. Weinstein, and L. Mahony Enalapril does not enhance exercise capacity in patients after Fontan procedure Circulation 96 1997 1507 1512
7. D.L.S. Yim, B.O. Jones, P.M.A. Alexander, Y. d'Udekem, and M.M.H. Cheung Effect of anti-heart failure therapy on diastolic function in children with single-ventricle circulations Cardiol. Young 25 2015 1293 1299
8. Pharmaceutical Benefits Scheme (PBS) Department of Health, Australian Government 2015
9. New Zealand Pharmaceutical Schedule Pharmaceutical Mangement Agency (PHARMAC) 2015
10. L.J. Burchill, H.J. Ross, and R.M. Wald Letter by Burchill et al. regarding article, "enalapril in infants with single ventricle: results of a multicenter randomized trial" Circulation 123 2011 e373
11. T.P. Singh Letter by Singh regarding article, "enalapril in infants with single ventricle: results of a multicenter randomized trial" Circulation 123 2011 e374
12. K. Francois, T. Bove, K. De Groote, J. Panzer, K. Vandekerckhove, B. Suys, and et al. Pleural effusions, water balance mediators and the influence of lisinopril after completion Fontan procedures Eur. J. Cardiothorac. Surg. 36 2009 57 62
13. N. Heragu, and L. Mahony Is captopril useful in decreasing pleural drainage in children after modified Fontan operation? Am. J. Cardiol. 84 1999 1109 1112 A1110
14. J.J. Lamberti, R.D. Mainwaring, R.L. Spicer, K.C. Uzark, and J.W. Moore Factors influencing perioperative morbidity during palliation of the univentricular heart Ann. Thorac. Surg. 60 1995 S550 S553
15. S. Fu, Z.-C. Feng, and S. Dietmar Factors influencing pleural effusion after Fontan operation: an analysis with 95 patients Chin. Med. Sci. J. 25 2010 38 43
16. A. Gupta, C. Daggett, S. Behera, M. Ferraro, W. Wells, and V. Starnes Risk factors for persistent pleural effusions after the extracardiac Fontan procedure J. Thorac. Cardiovasc. Surg. 127 2004 1664 1669
17. H. Ohuchi, S. Hasegawa, K. Yasuda, O. Yamada, Y. Ono, and S. Echigo Severely impaired cardiac autonomic nervous activity after the Fontan operation Circulation 104 2001 1513 1518
18. K.-J. Lee, S.-J. Yoo, H. Holtby, B. Grant, D. Mroczek, D. Wong, and et al. Acute effects of the ACE inhibitor enalaprilat on the pulmonary, cerebral and systemic blood flow and resistance after the bidirectional cavopulmonary connection Heart 97 2011 1343 1348
19. B.S. Moffett, R. Mattamal, E.C. Ocampo, and C.J. Petit Impact of pharmacotherapy on interstage outcomes in single ventricle infants Congenit. Heart Dis. 6 2011 286 293
20. S.J. Ghelani, C.F. Spurney, G.R. Martin, and R.R. Cross Impact of pharmacotherapy on interstage mortality and weight gain in children with single ventricle Congenit. Heart Dis. 8 2013 219 227
21. K. Francois, T. Bove, J. Panzer, K. De Groote, K. Vandekerckhove, H. De Wilde, and et al. Univentricular heart and Fontan staging: analysis of factors impacting on body growth Eur. J. Cardiothorac. Surg. 41 2012 e139 e145
22. Y.F. Cheung, D.J. Penny, and A.N. Redington Serial assessment of left ventricular diastolic function after Fontan procedure Heart 83 2000 420 424
23. Y. d'Udekem, M. Cheung, C.I. Sari, J. Inman, A. Ahimastos, N. Eikelis, and et al. Sympathetic and vascular dysfunction in adult patients with Fontan circulation Int. J. Cardiol. 167 2013 1333 1338
24. M. Gewillig The Fontan circulation Heart 91 2005 839 846
25. P.A.W. Anderson, R.E. Breitbart, B.W. McCrindle, L.A. Sleeper, A.M. Atz, D.T. Hsu, and et al. The Fontan patient: inconsistencies in medication therapy across seven pediatric heart network centers Pediatr. Cardiol. 31 2010 1219 1228
26. J.J.V. McMurray, S. Adamopoulos, S.D. Anker, A. Auricchio, M. Böhm, K. Dickstein, and et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology Developed in collaboration with the Heart Failure Association (HFA) of the ESC 33 2012 1787 1847
27. Yancy CW, M. Jessup, B. Bozkurt, J. Butler, Casey DE Jr., and et al. ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 2013 128 2013 e240 e327